Results 31 to 40 of about 5,155,633 (254)

COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects

open access: yes, 2021
The worldwide pandemic of coronavirus disease 2019 (COVID-19) has become an unprecedented challenge to global public health. With the intensification of the COVID-19 epidemic, the development of vaccines and therapeutic drugs against the etiological ...
Songtao Yang   +5 more
core   +1 more source

Provision of and trust in COVID‐19 vaccines information: Perspectives of people who have had COVID‐19

open access: yesHealth Expectations, 2023
Aim The aim of this study was to understand the provision and need, quality of and trust in COVID‐19 vaccines information from the perspectives of people who have had COVID‐19 infection. Method People who have had a COVID‐19 infection were approached via
Laura Schackmann   +4 more
doaj   +1 more source

Recombinant vaccines for COVID-19 [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2020
SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat, which needs effective therapeutics and vaccination strategies. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Considering the crucial role of SARS-CoV-2 spike (S) glycoprotein in virus attachment, entry, and induction of ...
Yadav, Tushar   +6 more
openaire   +3 more sources

Covid-19 vaccination in pregnancy

open access: yesBMJ, 2022
ABSTRACT Pregnancy is an independent risk factor for severe covid-19. Vaccination is the best way to reduce the risk for SARS-CoV-2 infection and limit its morbidity and mortality. The current recommendations from the World Health Organization, Centers for Disease Control and Prevention, and professional organizations are for pregnant,
Martina L, Badell   +3 more
openaire   +4 more sources

Real-World Effectiveness of Four Types of COVID-19 Vaccines

open access: yes, 2023
Background: There is a scarcity of evidence regarding the real-world effectiveness of coronavirus disease 2019 (COVID-19) vaccines. This was the first study to evaluate the effectiveness of four types of vaccines against asymptomatic and symptomatic ...
Mohannad Al Nsour   +19 more
core   +1 more source

Attitudes Toward COVID-19 Vaccines in Chinese Adolescents

open access: yesFrontiers in Medicine, 2021
Background: As COVID-19 vaccination programs are being implemented widely, it is important to examine the attitudes of adolescents toward the COVID-19 vaccine and its uptake.
Hong Cai   +16 more
doaj   +1 more source

What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments

open access: yes, 2021
Social media allow anti-vaxxers to quickly spread misinformation and false statements. This situation may lead to an increase in vaccine hesitancy. We wanted to characterize what arguments against COVID-19 vaccines run on Facebook in Poland.
Dominik Wawrzuta   +3 more
core   +1 more source

COVID-19: Vaccines and therapeutics

open access: yesBioorganic & Medicinal Chemistry Letters, 2022
Coronavirus disease 2019 (COVID-19) is a communicable disease triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as leading cause of death from a single infectious agent globally. Despite of rigorous protective measures, availability of multiple vaccines and with few approved therapeutics, the virus effect on the ...
Ponnampalli, Swapna   +2 more
openaire   +2 more sources

Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China

open access: yesHuman Vaccines & Immunotherapeutics, 2021
The COVID-19 pandemic has caused negative impacts both on populations’ health worldwide. COVID-19 vaccines are currently developed and tested in clinical trials.
Yutong Zhang, Xiaoqin Luo, Zheng Feei Ma
doaj   +1 more source

Overview of Nucleocapsid-Targeting Vaccines against COVID-19

open access: yes, 2023
The new SARS-CoV-2 coronavirus, which emerged in late 2019, is a highly variable causative agent of COVID-19, a contagious respiratory disease with potentially severe complications.
Irina Isakova-Sivak   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy